# FDA Inspection 965171 - Biomat USA Inc - March 22, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f2ed7177-af3b-4145-8cdc-3b2fb8fd5fa1
Source feed: FDA_Inspections

> FDA Inspection 965171 for Biomat USA Inc on March 22, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965171
- Company Name: Biomat USA Inc
- Inspection Date: 2016-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1097889 - 2019-06-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d0adea49-5d3a-421c-a620-21a37c4fe65f)
- [FDA Inspection 871898 - 2014-03-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f360df52-0d01-4451-8611-84b6b4efbb83)
- [FDA Inspection 770671 - 2012-03-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/467b20be-8de8-46ac-9633-2185cc4de07e)
- [FDA Inspection 649033 - 2010-02-11](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/43a13fb5-f559-4dcb-9265-0274762fa7eb)

Company: https://www.keypedia.com/companies/biomat-usa-inc/e9f8418c-a526-402b-a3e6-aa22026ab130

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d